TTR amyloidosis is increasingly recognized as a cause of diastolic heart failure and as much more common than previously thought. There are proven and investigational therapies that can slow or possibly stop this disesae.

In this interview, Rodney H. Falk, MD, FACC and Alison L. Bailey, MD FACC, with Jonathan R. Salik, MD, discuss Screening for Transthretin Amyloid Cardiomyopathy in Everyday Practice.

Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure

Keywords: ACCELLite, Heart Failure, Amyloid

< Back to Listings